84/100B44.305
USD
0.16
(0.36%)
Market Open
Last updated: · Delayed 15 min
Fair value62.64Plus-29%47Price 44.3178
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
Boston Scientific current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Boston Scientific's current ratio is 1.36: current assets of 8.16B USD against current liabilities of 5.98B USD due within a year.
- Today
- 1.36
- Average, 5 years
- 1.43
- Low, 5 years
- 1.08
- High, 5 years
- 1.90
Current ratio = current assets ÷ current liabilities = 8.16B ÷ 5.98B = 1.36
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 1.36 | 8.16B | 5.98B | |
| FY2025 | 31 Dec 2025 | 1.62 | 8.79B | 5.44B |
| FY2024 | 31 Dec 2024 | 1.08 | 6.92B | 6.40B |
| FY2023 | 31 Dec 2023 | 1.32 | 6.51B | 4.93B |
| FY2022 | 31 Dec 2022 | 1.51 | 5.76B | 3.80B |
| FY2021 | 31 Dec 2021 | 1.48 | 6.32B | 4.27B |
| FY2020 | 31 Dec 2020 | 1.82 | 6.69B | 3.68B |
| FY2019 | 31 Dec 2019 | 0.97 | 4.70B | 4.87B |
| FY2018 | 31 Dec 2018 | 0.76 | 4.00B | 5.26B |
| FY2017 | 31 Dec 2017 | 0.68 | 3.82B | 5.65B |
| FY2016 | 31 Dec 2016 | 0.90 | 3.24B | 3.59B |
| FY2015 | 31 Dec 2015 | 1.43 | 3.47B | 2.43B |
| FY2014 | 31 Dec 2014 | 1.51 | 3.39B | 2.25B |
| FY2013 | 31 Dec 2013 | 1.74 | 3.17B | 1.82B |
| FY2012 | 31 Dec 2012 | 1.71 | 3.02B | 1.77B |
| FY2011 | 31 Dec 2011 | 1.72 | 3.11B | 1.81B |
| FY2010 | 31 Dec 2010 | 1.39 | 3.62B | 2.61B |
| FY2009 | 31 Dec 2009 | 1.34 | 4.06B | 3.02B |
| FY2008 | 31 Dec 2008 | 1.70 | 5.45B | 3.21B |
| FY2007 | 31 Dec 2007 | 1.82 | 5.92B | 3.25B |
| FY2006 | 31 Dec 2006 | 1.86 | 4.90B | 2.63B |
| FY2005 | 31 Dec 2005 | 1.78 | 2.63B | 1.48B |
| FY2004 | 31 Dec 2004 | 1.26 | 3.29B | 2.61B |
| FY2003 | 31 Dec 2003 | 1.35 | 1.88B | 1.39B |
| FY2002 | 31 Dec 2002 | 1.31 | 1.21B | 923.00M |
| FY2001 | 31 Dec 2001 | 1.33 | 1.11B | 831.00M |
| FY2000 | 31 Dec 2000 | 1.21 | 992.00M | 819.00M |
| FY1999 | 31 Dec 1999 | 1.00 | 1.06B | 1.06B |
| FY1998 | 31 Dec 1998 | 0.78 | 1.27B | 1.62B |
| FY1997 | 31 Dec 1997 | 1.32 | 1.06B | 808.00M |
| FY1996 | 31 Dec 1996 | 1.61 | 748.90M | 463.80M |
| FY1995 | 31 Dec 1995 | 1.98 | 537.00M | 271.00M |
| FY1994 | 31 Dec 1994 | 3.58 | 263.80M | 73.70M |
| FY1993 | 31 Dec 1993 | 3.78 | 216.10M | 57.10M |
| FY1992 | 31 Dec 1992 | 5.55 | 236.50M | 42.60M |
| FY1991 | 31 Dec 1991 | 3.47 | 89.10M | 25.70M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.36 | 8.16B | 5.98B |
| Q2 FY2026 | 30 Jun 2026 | 1.24 | 7.97B | 6.43B |
| Q1 FY2026 | 31 Mar 2026 | 1.90 | 8.68B | 4.57B |
| Q4 FY2025 | 31 Dec 2025 | 1.62 | 8.79B | 5.44B |
| Q3 FY2025 | 30 Sept 2025 | 1.51 | 8.04B | 5.33B |
| Q2 FY2025 | 30 Jun 2025 | 1.37 | 7.12B | 5.19B |
| Q1 FY2025 | 31 Mar 2025 | 1.45 | 7.34B | 5.06B |
| Q4 FY2024 | 31 Dec 2024 | 1.08 | 6.92B | 6.40B |
| Q3 FY2024 | 30 Sept 2024 | 1.48 | 8.76B | 5.91B |
| Q2 FY2024 | 30 Jun 2024 | 1.61 | 8.99B | 5.58B |
| Q1 FY2024 | 31 Mar 2024 | 1.66 | 8.19B | 4.92B |
| Q4 FY2023 | 31 Dec 2023 | 1.32 | 6.51B | 4.93B |
| Q3 FY2023 | 30 Sept 2023 | 1.42 | 6.50B | 4.58B |
| Q2 FY2023 | 30 Jun 2023 | 1.29 | 5.89B | 4.56B |
| Q1 FY2023 | 31 Mar 2023 | 1.40 | 5.70B | 4.08B |
| Q4 FY2022 | 31 Dec 2022 | 1.51 | 5.76B | 3.80B |
| Q3 FY2022 | 30 Sept 2022 | 1.45 | 5.14B | 3.55B |
| Q2 FY2022 | 30 Jun 2022 | 1.31 | 5.08B | 3.88B |
| Q1 FY2022 | 31 Mar 2022 | 1.18 | 5.07B | 4.28B |
| Q4 FY2021 | 31 Dec 2021 | 1.48 | 6.32B | 4.27B |
| Q3 FY2021 | 30 Sept 2021 | 1.55 | 6.23B | 4.02B |
| Q2 FY2021 | 30 Jun 2021 | 1.66 | 6.76B | 4.07B |
| Q1 FY2021 | 31 Mar 2021 | 1.80 | 6.10B | 3.39B |
| Q4 FY2020 | 31 Dec 2020 | 1.82 | 6.69B | 3.68B |
| Q3 FY2020 | 30 Sept 2020 | 1.87 | 6.16B | 3.30B |
| Q2 FY2020 | 30 Jun 2020 | 1.87 | 5.80B | 3.11B |
| Q1 FY2020 | 31 Mar 2020 | 1.21 | 4.82B | 3.98B |
| Q4 FY2019 | 31 Dec 2019 | 0.97 | 4.70B | 4.87B |
| Q3 FY2019 | 30 Sept 2019 | 1.14 | 4.85B | 4.25B |
| Q2 FY2019 | 30 Jun 2019 | 1.31 | 6.33B | 4.85B |
| Q1 FY2019 | 31 Mar 2019 | 1.39 | 6.23B | 4.48B |
| Q4 FY2018 | 31 Dec 2018 | 0.76 | 4.00B | 5.26B |
| Q3 FY2018 | 30 Sept 2018 | 0.78 | 3.97B | 5.08B |
| Q2 FY2018 | 30 Jun 2018 | 0.83 | 3.93B | 4.75B |
| Q1 FY2018 | 31 Mar 2018 | 0.82 | 4.08B | 4.99B |
| Q4 FY2017 | 31 Dec 2017 | 0.68 | 3.82B | 5.65B |
| Q3 FY2017 | 30 Sept 2017 | 0.72 | 3.48B | 4.83B |
| Q2 FY2017 | 30 Jun 2017 | 0.75 | 3.22B | 4.30B |
| Q1 FY2017 | 31 Mar 2017 | 0.87 | 3.03B | 3.49B |
| Q4 FY2016 | 31 Dec 2016 | 0.90 | 3.24B | 3.59B |
| Q3 FY2016 | 30 Sept 2016 | 1.05 | 3.18B | 3.02B |
| Q2 FY2016 | 30 Jun 2016 | 1.05 | 3.33B | 3.18B |
| Q1 FY2016 | 31 Mar 2016 | 1.21 | 3.16B | 2.61B |
| Q4 FY2015 | 31 Dec 2015 | 1.43 | 3.47B | 2.43B |
| Q3 FY2015 | 30 Sept 2015 | 1.55 | 3.46B | 2.24B |
| Q2 FY2015 | 30 Jun 2015 | 1.95 | 3.77B | 1.94B |
| Q1 FY2015 | 31 Mar 2015 | 1.29 | 3.19B | 2.46B |
| Q4 FY2014 | 31 Dec 2014 | 1.51 | 3.39B | 2.25B |
| Q3 FY2014 | 30 Sept 2014 | 1.74 | 3.18B | 1.82B |
| Q2 FY2014 | 30 Jun 2014 | 1.81 | 3.21B | 1.77B |
| Q1 FY2014 | 31 Mar 2014 | 1.71 | 2.94B | 1.72B |
| Q4 FY2013 | 31 Dec 2013 | 1.74 | 3.17B | 1.82B |
| Q3 FY2013 | 30 Sept 2013 | 1.85 | 3.53B | 1.90B |
| Q2 FY2013 | 30 Jun 2013 | 1.41 | 3.50B | 2.48B |
| Q1 FY2013 | 31 Mar 2013 | 1.90 | 3.10B | 1.64B |
| Q4 FY2012 | 31 Dec 2012 | 1.71 | 3.02B | 1.77B |
| Q3 FY2012 | 30 Sept 2012 | 1.80 | 3.17B | 1.76B |
| Q2 FY2012 | 30 Jun 2012 | 1.73 | 3.11B | 1.79B |
| Q1 FY2012 | 31 Mar 2012 | 1.85 | 3.09B | 1.67B |
| Q4 FY2011 | 31 Dec 2011 | 1.72 | 3.11B | 1.81B |
| Q3 FY2011 | 30 Sept 2011 | 1.70 | 3.21B | 1.89B |
| Q2 FY2011 | 30 Jun 2011 | 1.66 | 3.15B | 1.89B |
| Q1 FY2011 | 31 Mar 2011 | 1.75 | 3.57B | 2.04B |
| Q4 FY2010 | 31 Dec 2010 | 1.39 | 3.62B | 2.61B |
| Q3 FY2010 | 30 Sept 2010 | 1.20 | 3.56B | 2.96B |
| Q2 FY2010 | 30 Jun 2010 | 1.07 | 3.99B | 3.72B |
| Q1 FY2010 | 31 Mar 2010 | 1.29 | 3.75B | 2.91B |
| Q4 FY2009 | 31 Dec 2009 | 1.34 | 4.06B | 3.02B |
| Q3 FY2009 | 30 Sept 2009 | 1.82 | 4.96B | 2.73B |
| Q2 FY2009 | 30 Jun 2009 | 1.74 | 4.80B | 2.75B |
| Q1 FY2009 | 31 Mar 2009 | 1.88 | 4.57B | 2.43B |
| Q4 FY2008 | 31 Dec 2008 | 1.69 | 5.45B | 3.23B |
| Q3 FY2008 | 30 Sept 2008 | 1.49 | 5.29B | 3.54B |
| Q2 FY2008 | 30 Jun 2008 | 1.70 | 5.17B | 3.04B |
| Q1 FY2008 | 31 Mar 2008 | 1.54 | 5.24B | 3.39B |
| Q4 FY2007 | 31 Dec 2007 | 1.82 | 5.92B | 3.25B |
| Q3 FY2007 | 30 Sept 2007 | 1.39 | 4.69B | 3.38B |
| Q2 FY2007 | 30 Jun 2007 | 1.66 | 4.94B | 2.97B |
| Q1 FY2007 | 31 Mar 2007 | 1.93 | 4.58B | 2.37B |
| Q4 FY2006 | 31 Dec 2006 | 1.86 | 4.90B | 2.63B |
| Q3 FY2006 | 30 Sept 2006 | 1.94 | 4.75B | 2.45B |
| Q2 FY2006 | 30 Jun 2006 | 2.03 | 4.41B | 2.17B |
| Q1 FY2006 | 31 Mar 2006 | 1.41 | 2.87B | 2.04B |
| Q4 FY2005 | 31 Dec 2005 | 1.78 | 2.63B | 1.48B |
| Q3 FY2005 | 30 Sept 2005 | 2.42 | 2.76B | 1.14B |
| Q2 FY2005 | 30 Jun 2005 | 1.55 | 2.72B | 1.76B |
| Q1 FY2005 | 31 Mar 2005 | 1.55 | 2.76B | 1.78B |
| Q4 FY2004 | 31 Dec 2004 | 1.26 | 3.29B | 2.61B |
| Q3 FY2004 | 30 Sept 2004 | 1.62 | 3.02B | 1.87B |
| Q2 FY2004 | 30 Jun 2004 | 1.69 | 2.67B | 1.59B |
| Q1 FY2004 | 31 Mar 2004 | 1.14 | 1.99B | 1.74B |
| Q4 FY2003 | 31 Dec 2003 | 1.35 | 1.88B | 1.39B |
| Q3 FY2003 | 30 Sept 2003 | 1.05 | 1.51B | 1.44B |
| Q2 FY2003 | 30 Jun 2003 | 1.24 | 1.38B | 1.11B |
| Q1 FY2003 | 31 Mar 2003 | 1.14 | 1.24B | 1.09B |
| Q4 FY2002 | 31 Dec 2002 | 1.31 | 1.21B | 923.00M |
| Q3 FY2002 | 30 Sept 2002 | 1.14 | 1.17B | 1.03B |
| Q2 FY2002 | 30 Jun 2002 | 1.01 | 1.07B | 1.06B |
| Q1 FY2002 | 31 Mar 2002 | 1.26 | 1.12B | 889.00M |
| Q4 FY2001 | 31 Dec 2001 | 1.33 | 1.11B | 831.00M |
| Q3 FY2001 | 30 Sept 2001 | 1.09 | 1.03B | 941.00M |
| Q2 FY2001 | 30 Jun 2001 | 0.88 | 998.00M | 1.13B |
| Q1 FY2001 | 31 Mar 2001 | 1.18 | 1.06B | 899.00M |
| Q4 FY2000 | 31 Dec 2000 | 1.21 | 992.00M | 819.00M |
| Q3 FY2000 | 30 Sept 2000 | 1.16 | 935.00M | 803.00M |
| Q2 FY2000 | 30 Jun 2000 | 1.03 | 959.00M | 932.00M |
| Q1 FY2000 | 31 Mar 2000 | 0.97 | 1.02B | 1.04B |
| Q4 FY1999 | 31 Dec 1999 | 1.00 | 1.06B | 1.06B |
| Q3 FY1999 | 30 Sept 1999 | 1.05 | 1.10B | 1.04B |
| Q2 FY1999 | 30 Jun 1999 | 1.26 | 1.19B | 945.00M |
| Q1 FY1999 | 31 Mar 1999 | 0.81 | 1.30B | 1.61B |
| Q4 FY1998 | 31 Dec 1998 | 0.78 | 1.27B | 1.62B |
| Q3 FY1998 | 30 Sept 1998 | 0.52 | 1.37B | 2.64B |
| Q2 FY1998 | 30 Jun 1998 | 3.45 | 1.26B | 365.20M |
| Q1 FY1998 | 31 Mar 1998 | 3.15 | 1.20B | 380.20M |
| Q4 FY1997 | 31 Dec 1997 | 1.32 | 1.06B | 808.00M |
| Q3 FY1997 | 30 Sept 1997 | 1.50 | 1.00B | 667.70M |
| Q2 FY1997 | 30 Jun 1997 | 1.35 | 909.20M | 673.50M |
| Q1 FY1997 | 31 Mar 1997 | 1.67 | 764.40M | 457.00M |
| Q4 FY1996 | 31 Dec 1996 | 1.61 | 748.90M | 463.80M |
| Q3 FY1996 | 30 Sept 1996 | 1.30 | 642.50M | 492.70M |
| Q2 FY1996 | 30 Jun 1996 | 1.25 | 583.30M | 465.30M |
| Q1 FY1996 | 31 Mar 1996 | 1.39 | 574.10M | 412.80M |
| Q4 FY1995 | 31 Dec 1995 | 1.98 | 537.00M | 271.00M |
| Q3 FY1995 | 30 Sept 1995 | 3.31 | 459.70M | 138.70M |
| Q2 FY1995 | 30 Jun 1995 | 2.09 | 530.70M | 254.40M |
| Q1 FY1995 | 31 Mar 1995 | 1.79 | 521.80M | 291.40M |
| Q4 FY1994 | 31 Dec 1994 | 3.58 | 263.80M | 73.70M |
| Q3 FY1994 | 30 Sept 1994 | 4.08 | 254.70M | 62.50M |
| Q2 FY1994 | 30 Jun 1994 | 4.43 | 238.50M | 53.80M |
| Q1 FY1994 | 31 Mar 1994 | 3.69 | 228.60M | 61.90M |
| Q4 FY1993 | 31 Dec 1993 | 3.78 | 216.10M | 57.10M |
| Q3 FY1993 | 30 Sept 1993 | 3.58 | 214.30M | 59.90M |
| Q2 FY1993 | 30 Jun 1993 | 4.26 | 214.50M | 50.40M |
| Q1 FY1993 | 31 Mar 1993 | 5.30 | 256.40M | 48.40M |
| Q4 FY1992 | 31 Dec 1992 | 5.55 | 236.50M | 42.60M |
| Q3 FY1992 | 30 Sept 1992 | 4.80 | 223.20M | 46.50M |
| Q2 FY1992 | 30 Jun 1992 | 7.77 | 207.40M | 26.70M |
| Q1 FY1992 | 31 Mar 1992 | 2.02 | 91.90M | 45.40M |
| Q4 FY1991 | 31 Dec 1991 | 3.47 | 89.10M | 25.70M |
| Q3 FY1991 | 30 Sept 1991 | — | — | — |
| Q2 FY1991 | 30 Jun 1991 | — | — | — |
| Q1 FY1991 | 31 Mar 1991 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about Boston Scientific's current ratio
Source: Financial Modeling Prep